Lytica Therapeutics
Lytica Therapeutics
  • Home
  • Team
  • News
  • Careers
  • Contact
  • More
    • Home
    • Team
    • News
    • Careers
    • Contact
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Team
  • News
  • Careers
  • Contact

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

James LaTorre, CFA

Loren Walensky, MD, PhD

James LaTorre, CFA

Chief Executive Officer

Rida Mourtada, PhD

Loren Walensky, MD, PhD

James LaTorre, CFA

Chief Scientific Officer

Loren Walensky, MD, PhD

Loren Walensky, MD, PhD

Loren Walensky, MD, PhD

Scientific Cofounder

Daniel Cohen, PhD

Killian O'Brien, PhD

Loren Walensky, MD, PhD

Associate Principal Scientist, Protein Chemistry

Lip Nam Loh, PhD

Killian O'Brien, PhD

Killian O'Brien, PhD

Associate Principal Scientist, Biology

Killian O'Brien, PhD

Killian O'Brien, PhD

Killian O'Brien, PhD

Senior Scientist, Biology

Isabelle Hanna

Jenise Martinez

Isabelle Hanna

Senior Research Associate, Biology

John Bajacan

Jenise Martinez

Isabelle Hanna

Scientist, Chemistry

Jenise Martinez

Jenise Martinez

Arianna Finnegan

Research Associate, Biology

Arianna Finnegan

Arianna Finnegan

Arianna Finnegan

Operations Manager

Scientific Advisory Board

James Balkovec, PhD

Steve Projan, PhD, FAAM

Joel Freundlich, PhD

Principal at ChemTract Consulting

Co-inventor of Caspofungin, the first glucan synthase inhibitor (GSi) for the treatment of serious fungal infections

Joel Freundlich, PhD

Steve Projan, PhD, FAAM

Joel Freundlich, PhD

Professor

Pharmacology, Physiology & Neuroscience

New Jersey Medical School

Rutgers University

Steve Projan, PhD, FAAM

Steve Projan, PhD, FAAM

Steve Projan, PhD, FAAM

Former Head of the Infectious Diseases & Vaccines Innovative Medicines unit (iMED) at MedImmune

Former VP and Global Head of Infectious Diseases at the Novartis Institutes for Biomedical Research

Edward Ha, PhD

Robert Lutz, PhD

Steve Projan, PhD, FAAM

Head of ADC Innovation

Iksuda Therapeutics

Robert Lutz, PhD

Robert Lutz, PhD

Robert Lutz, PhD

CSO, Iksuda Therapeutics

Former VP of Translational R&D, Immunogen

Our partners

Copyright © 2019-2022 Lytica Therapeutics, Inc - All Rights Reserved.


Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

DeclineAccept & Close